Search details
1.
Switch to a raltegravir-based antiretroviral regimen in people with HIV and non-alcoholic fatty liver disease: A randomized controlled trial.
HIV Med
; 25(1): 135-142, 2024 Jan.
Article
in English
| MEDLINE | ID: mdl-37641534
2.
FIB-4 Improves LSM-Based Prediction of Complications in Overweight or Obese Patients With Compensated Advanced Chronic Liver Disease.
Clin Gastroenterol Hepatol
; 20(10): 2396-2398.e3, 2022 Oct.
Article
in English
| MEDLINE | ID: mdl-33716139
3.
NASH in HIV.
Curr HIV/AIDS Rep
; 17(6): 601-614, 2020 12.
Article
in English
| MEDLINE | ID: mdl-32984925
4.
Increased Serum Fibroblast Growth Factor 23 Predicts Mortality in People With HIV/HCV Coinfection.
J Acquir Immune Defic Syndr
; 94(3): 273-279, 2023 11 01.
Article
in English
| MEDLINE | ID: mdl-37368933
5.
Development and validation of an ensemble machine learning framework for detection of all-cause advanced hepatic fibrosis: a retrospective cohort study.
Lancet Digit Health
; 4(3): e188-e199, 2022 03.
Article
in English
| MEDLINE | ID: mdl-35216753
6.
Metabolic and cardiovascular complications after virological cure in hepatitis C: What awaits beyond.
World J Gastroenterol
; 27(17): 1959-1972, 2021 May 07.
Article
in English
| MEDLINE | ID: mdl-34007133
7.
Non-alcoholic fatty liver disease in premenopausal women with polycystic ovary syndrome: A systematic review and meta-analysis.
JGH Open
; 5(4): 434-445, 2021 Apr.
Article
in English
| MEDLINE | ID: mdl-33860093
8.
Prevalence and predictors of nonalcoholic fatty liver disease in South Asian women with polycystic ovary syndrome.
World J Gastroenterol
; 26(44): 7046-7060, 2020 Nov 28.
Article
in English
| MEDLINE | ID: mdl-33311949
9.
Impacts of the COVID-19 pandemic on hepatitis C elimination in Canada: Where do we go from here?
Can Liver J
; 5(4): 441-444, 2022 Nov.
Article
in English
| MEDLINE | ID: mdl-38144406
Results
1 -
9
de 9
1
Next >
>>